MicroRNA-218-5p affects lung adenocarcinoma progression through targeting endoplasmic reticulum oxidoreductase 1 alpha.

MicroRNA-218-5p affects lung adenocarcinoma progression through targeting endoplasmic reticulum oxidoreductase 1 alpha.
复制标题

DOI:
10.1080/21655979.2022.2063537
复制
发表时间:
2022-04
期刊:
影响因子:
4.9
通讯作者:
--
中科院分区:
生物学2区
文献类型:
--
作者:

文献摘要

参考文献

被引文献

相似文献

肺腺癌是一种严重威胁人类健康的恶性肿瘤。然而,土地利用变化与发展的内在机制在很大程度上仍不清楚。本研究旨在探讨miR-218- 5 p在LUAD中的功能。MiR-218- 5 p和内质网氧化还原酶1 α(ERO 1A)通过生物信息学分析分别被筛选为LUAD中不同下调和上调的RNA。细胞功能分析的结果表明,miR-218- 5 p的强制表达显著抑制LUAD中的细胞活力、侵袭和迁移。生物信息学分析表明,miR-218- 5 p可能与ERO 1A mRNA的3 '端非翻译区相互作用。随后,采用western blot和双荧光素酶报告基因分析来鉴定它们之间的相互作用。ERO 1A过表达逆转了miR-218- 5 p对LUAD细胞进展的抑制作用,表明miR-218- 5 p/ERO 1A轴在抑制癌症发展中的意义。我们还观察到,这个调节轴抑制血管生成LUAD。因此,miR-218- 5 p/ERO 1A轴在LUAD细胞的生长过程中起重要作用,为LUAD治疗方案的制定提供了有价值的线索。
Lung adenocarcinoma (LUAD) severely threatens the health of people owing to its lethality. Nonetheless, the underlying mechanisms on LUAD development remain unclear to a great extent. This work aimed to probe the functions of miR-218-5p in LUAD. MiR-218-5p and endoplasmic reticulum oxidoreductase 1 alpha (ERO1A) were screened as differently downregulated and upregulated RNAs in LUAD, respectively, by bioinformatics analyses. The results of cell functional assays stated that enforced expression of miR-218-5p notably restrained cell viability, invasion, and migration in LUAD. MiR-218-5p may interact with 3’-untranslated region of ERO1A mRNA as analyzed by bioinformatics. Afterward, western blot and dual-luciferase reporter gene analyses were introduced to identify their interaction. ERO1A overexpression reversed the suppressive impacts of miR-218-5p on LUAD cell progression, indicating the implication of miR-218-5p/ERO1A axis in suppressing cancer development. We also observed that this regulatory axis suppressed angiogenesis in LUAD. Taken together, miR-218-5p/ERO1A axis exerted an imperative role in LUAD cell progression, which provides a valuable clue for the development of LUAD therapeutic regimen.
DOI: 10.1093/annonc/mds226
发表时间: 2012-10-01
期刊: ANNALS OF ONCOLOGY
影响因子: 50.5
作者:
Peters, S.;Adjei, A. A.;Felip, E.
通讯作者: Felip, E.
miR-423-5p 导致胶质母细胞瘤的恶性表型和替莫唑胺化疗耐药
DOI: 10.1093/neuonc/now129
发表时间: 2017-01-01
期刊: NEURO-ONCOLOGY
影响因子: 15.9
作者:
Li, Shouwei;Zeng, Ailiang;You, Yongping
通讯作者: You, Yongping
DOI: 10.1098/rsob.170070
发表时间: 2017-09
期刊: Open biology
影响因子: 5.8
作者:
Blandin Knight S;Crosbie PA;Balata H;Chudziak J;Hussell T;Dive C
通讯作者: Dive C
DOI: 10.1002/cbin.11454
发表时间: 2020-12
影响因子: 3.9
作者:
Shi X;Wu J;Liu Y;Jiang Y;Zhi C;Li J
通讯作者: Li J
ERO1L促进IL6/sIL6R信号传导并调节MUC16表达促进CA125分泌和肺癌细胞转移
DOI: 10.1038/s41419-020-03067-8
发表时间: 2020-10-14
影响因子: 9
作者:
Lei Y;Zang R;Lu Z;Zhang G;Huang J;Liu C;Wang Z;Mao S;Che Y;Wang X;Zheng S;Fang L;Sun N;He J
通讯作者: He J